logo
Select company
Select metric
25.47%EBITDA Margin
VS
Market
72
Sector
88
Industry
100
History
77
$ 2.84Close
$ 2.77 - $ 6.93 52-Week Range
Ticker Information

Ticker

BTMD

Company Name

BIOTE CORP

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NASDAQ

BIOTE CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BTMD - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ 50.71M25.47%$ 199.07M
3/31/2025$ 38.89M19.5%$ 199.38M
12/31/2024$ 19.52M9.9%$ 197.19M
9/30/2024$ 27.19M14.08%$ 193.06M
6/30/2024$ 22.07M11.79%$ 187.23M
3/31/2024$ 23.58M12.59%$ 187.32M
12/31/2023$ 15.85M8.55%$ 185.36M
9/30/2023$ 14.28M7.75%$ 184.14M
6/30/2023$ 3.29M1.82%$ 180.56M
3/31/2023$ 2.82M1.64%$ 172.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOTE CORP's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, BIOTE CORP's average EBITDA % has been 19.32%.
  • The median EBITDA % for BIOTE CORP during this period was 12.19%
  • BIOTE CORP reached its highest EBITDA % over the past 5 years at 70.57%.
  • The lowest EBITDA % recorded by BIOTE CORP in the same timeframe 1.64%

BIOTE CORP's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
PBYI : PUMA BIOTECHNOLOGY INC 26.59%AMWL : AMERICAN WELL CORP -33.64%INFU : INFUSYSTEM HOLDINGS INC 16.81%MGNX : MACROGENICS INC -16.92%JYNT : JOINT CORP 1.02%QIPT : QUIPT HOME MEDICAL CORP 20.93%AGEN : AGENUS INC -68.82%ATRA : ATARA BIOTHERAPEUTICS INC 13.18%CHRS : COHERUS ONCOLOGY INC 140.73%IRWD : IRONWOOD PHARMACEUTICALS INC 26.07%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BIOTE CORP is calculated as follows: EBITDA [ $ 0 ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

BTMD - EBITDA Margin, Last 5 years

1.64%

Minimum

Mar 31, 2023

70.57%

Maximum

Jun 30, 2022

19.32%

Average

12.19%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%